Keryx Biopharmaceuticals (KERX)
Keryx Biopharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -9.114M | -8.375M | -10.25M | -3.096M | -6.405M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.01M | 0.014M | 0.012M | 0.01M | 0.011M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.646M | 0.283M | 0.472M | 0.519M | 0.573M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 0.656M | 0.297M | 0.484M | 0.529M | 0.584M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -0.091M | 0.453M | 2.668M | -0.113M | 0.399M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -8.549M | -7.625M | -7.095M | -2.68M | -5.422M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.002M | -0.009M | -0.014M | -0.009M | -0.025M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -5.001M | 5.052M | 0.053M | -9.116M | -0.10M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -5.003M | 5.043M | 0.039M | -9.125M | -0.125M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 0.00 | 1.681M | 32.15M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.00 | 1.681M | 32.15M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -13.55M | -2.582M | -5.375M | 20.34M | -5.547M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 35.25M | 28.41M | 35.25M | 37.83M | 43.21M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 21.70M | 35.25M | 37.83M | 43.21M | 22.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
